LeonaBio (LONA) EPS (Weighted Average and Diluted) (2021 - 2026)
LeonaBio (LONA) reported EPS (Weighted Average and Diluted) of -$1.73 for Q1 2026, up 26.07% year-over-year from -$1.37 in Q1 2025, and up 90.85% quarter-over-quarter from -$18.9 in Q4 2025.
LeonaBio (LONA) EPS (Weighted Average and Diluted) (2021 - 2026) Analysis & Trends
LeonaBio (LONA) has 6 years of EPS (Weighted Average and Diluted) data on file, last reported at -$1.73 in Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at -$1.73, up 26.07% year-over-year; the trailing twelve-month figure through Mar 2026 was -$22.49 (down 56.62% YoY), and the FY2025 annual result was -$24.7, up 1.95% from the prior year.
- EPS (Weighted Average and Diluted) advanced to -$1.73 in Q1 2026 per LONA's latest filing, from -$18.9 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at -$0.18 in Q2 2025 and troughed at -$18.9 in Q4 2025.
- A 5-year average of -$2.54 and a median of -$0.78 in 2023 frame the typical range for EPS (Weighted Average and Diluted).
- The sharpest annual moves came in 2024 and 2025: EPS (Weighted Average and Diluted) sank 757.47% in 2024, then soared 77.48% in 2025.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.79 in 2022, then grew by 10.13% to -$0.71 in 2023, then sank by 443.66% to -$3.86 in 2024, then tumbled by 389.64% to -$18.9 in 2025, then surged by 90.85% to -$1.73 in 2026.
- Business Quant data shows LONA's EPS (Weighted Average and Diluted) at -$1.73 in Q1 2026, -$18.9 in Q4 2025, and -$1.68 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.61 |
| 10 | LeonaBio | 154.12 Mn | 86.44 Mn | - | -1.73 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.73 |
| Dec 31, 2025 | -18.90 |
| Sep 30, 2025 | -1.68 |
| Jun 30, 2025 | -0.18 |
| Mar 31, 2025 | -2.34 |
| Dec 31, 2024 | -3.86 |
| Sep 30, 2024 | -7.46 |
| Jun 30, 2024 | -0.70 |
| Mar 31, 2024 | -0.69 |
| Dec 31, 2023 | -0.71 |
| Sep 30, 2023 | -0.87 |
| Jun 30, 2023 | -0.78 |
| Mar 31, 2023 | -0.73 |
| Dec 31, 2022 | -0.79 |
| Sep 30, 2022 | -0.53 |
| Jun 30, 2022 | -0.65 |
| Mar 31, 2022 | -0.56 |
| Dec 31, 2021 | -0.44 |
| Sep 30, 2021 | -0.42 |